Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Safety of Convalescent Plasma to Treat COVID-19 Patients With Moderate and Above Illness

NCT04516954 is registered in ClinicalTrials.gov with Vinmec Research Institute of Stem Cell and Gene Technology as lead sponsor.

NCT NCT04516954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04516954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Safety of Convalescent Plasma to Treat COVID-19 Patients With Moderate and Above Illness
Lead sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2020
Completion date
April 30, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19